➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Mallinckrodt
Medtronic
Johnson and Johnson
Express Scripts

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for ISV-305

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug ISV-305?

ISV-305 is an investigational drug.

There have been 15 clinical trials for ISV-305. The most recent clinical trial was a Phase 3 trial, which was initiated on December 4th 2019.

The most common disease conditions in clinical trials are Cataract, Inflammation, and Conjunctivitis. The leading clinical trial sponsors are InSite Vision, Bausch & Lomb Incorporated, and University of California, San Diego.

There are two US patents protecting this investigational drug and forty-two international patents.

Recent Clinical Trials for ISV-305
TitleSponsorPhase
Rib Fracture Analgesia Using CryoanalgesiaEpimed InternationalPhase 4
Rib Fracture Analgesia Using CryoanalgesiaUniversity of FloridaPhase 4
Rib Fracture Analgesia Using CryoanalgesiaUniversity of California, San DiegoPhase 4

See all ISV-305 clinical trials

Clinical Trial Summary for ISV-305

Top disease conditions for ISV-305
Top clinical trial sponsors for ISV-305

See all ISV-305 clinical trials

US Patents for ISV-305

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ISV-305   Start Trial Methods and compositions for producing hepatocyte-like cells The Board of Trustees of the Leland Stanford Junior University (Stanford, CA)   Start Trial
ISV-305   Start Trial 1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors Janssen Pharmaceutica NV (Beerse, BE)   Start Trial
ISV-305   Start Trial Pharmaceutical compounds Cascadian Therapeutics, Inc. (Seattle, WA)   Start Trial
ISV-305   Start Trial Fused pyrimidines as inhibitors of P97 complex Cleave Biosciences, Inc. (Burlingame, CA)   Start Trial
ISV-305   Start Trial Methods of treating vestibular schwannoma and reducing hearing or neurite loss caused by vestibular schwannoma Massachusetts Eye and Ear Infirmary (Boston, MA)   Start Trial
ISV-305   Start Trial Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D- ]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamate Millennium Pharmacetuicals, Inc. (Cambridge, MA)   Start Trial
ISV-305   Start Trial Cured gel and method of making ATRIUM MEDICAL CORPORATION (Merrimack, NH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ISV-305

Drugname Country Document Number Estimated Expiration Related US Patent
ISV-305 Canada CA2959117 2033-09-19   Start Trial
ISV-305 Denmark DK3046628 2033-09-19   Start Trial
ISV-305 European Patent Office EP3046628 2033-09-19   Start Trial
ISV-305 European Patent Office EP3685884 2033-09-19   Start Trial
ISV-305 Spain ES2767062 2033-09-19   Start Trial
ISV-305 Japan JP2016529920 2033-09-19   Start Trial
ISV-305 Japan JP2020114237 2033-09-19   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Mallinckrodt
Medtronic
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.